Khaniukov O. O., Sapozhnychenko L. V.

CHRONIC HEART FAILURE OF ISHEMIC ETIOLOGY: GENDER DIFFERENCES AND COMORBIDITIES

---

Show/Download

About the author:

Khaniukov O. O., Sapozhnychenko L. V.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

This study aims to determine and analyse gender characteristics and prevalence of comorbidities in patients with chronic heart failure of ischaemic genesis depending on left ventricular ejection fraction. We examined 216 patients with chronic heart failure (CHF) against the background of coronary heart disease. It was found that CHF of ischaemic aetiology was significantly more common in men than women, with a prevalence of 68.1% and 31.9%, respectively. In addition, at the time of hospitalisation, women were older than men. Hypertension was significantly more common in patients with heart failure (HF) with preserved ejection fraction, with a prevalence of 92% (p<0.05). Men are more prone to CHF with reduced ejection fraction, and women are more likely to have CHF with preserved ejection fraction. Non-cardiac comorbidities in patients with HF with reduced ejection fraction were represented by chronic obstructive pulmonary disease (13.1%), congestive pneumonia (6.6%) and a history of stroke or transient ischaemic attack (11.5%). Patients with HF and moderately reduced ejection fraction were more likely to have nonalcoholic fatty liver disease (51.9%), as well as chronic kidney disease and thyroid dysfunction (27.1% and 24.3%, respectively), compared with patients with preserved ejection fraction.

Tags:

Bibliography:

1. Verhestraeten C, Weijers G, Debleu D, Ciarka A, Goethals M, Droogmans S, et al. Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement. PLoS One. 2020 Dec 31;15(12):e0244485. DOI: 10.1371/journal.pone.0244485.
2. Moe G. Heart failure with multiple comorbidities. Curr Opin Cardiol. 2016 Mar;31(2):209-16. DOI:  10.1097/HCO.0000000000000257.
3. Campbell P, Krim S, Ventura H. The Bi-directional Impact of Two Chronic Illnesses: Heart Failure and Diabetes - A review of the Epidemiology and Outcomes. Card Fail Rev. 2015 Apr;1(1):8-10. DOI: 10.15420/cfr.2015.01.01.8.
4. Lawson CA, Solis-Trapala I, Dahlstrom U, Mamas M, Jaarsma T, Kadam UT, et al. Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry. PLoS Med. 2018 Mar;15(3):e1002540. DOI: 10.1371/journal.pmed.1002540.
5. Porter TR, Shillcutt SK, Adams MS, Desjardins G, Glas KE, Olson JJ, et al. Guidelines for the Use of Echocardiography as a Monitor for Therapeutic Intervention in Adults: A Report from the American Society of Echocardiography 2015. J. Am. Soc. Echocard. 2015;28:40-56. DOI: 10.1016/j.echo.2014.09.009.
6. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. DOI: 10.1093/eurheartj/ehab368.
7. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627-3639.
8. Antomonov MY. Matematicheskaya obrabotka I analiz medico-biologicheskich dannych. Kyyiv: Medinform; 2017. 578 s. Dostupno: http:// www.health.gov.ua/www.nsf/16a436f1b0cca21ec22571b300253d46/522e94120f630ce5c225803b004b3867/$FILE/Antomonov_monogr_ titul%2BOGLAVL%2Bvvedenie.pdf.
9. Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, et al. Sex differences in heart failure. Eur Heart J. 2019 Dec 14;40(47):3859-3868c. DOI: 10.1093/eurheartj/ehz835.
10. Björck L, Lundberg C, Schaufelberger M, Lissner L, Adiels M, Rosengren A. Body mass index in women aged 18 to 45 and subsequent risk of heart failure. Eur J Prev Cardiol. 2020;27(11):1165-1174. DOI: 10.1177/2047487319882510.
11. Martinez SC, Byku M, Novak EL, Cedars AM, Eghtesady P, Ludbrook PA, et al. Increased Body Mass Index Is Associated with Congestive Heart Failure and Mortality in Adult Fontan Patients. Eur J Prev Cardiol. Congenit Heart Dis. 2016;11(1):71-9. DOI: 10.1111/chd.12296.
12. Gargiulo P, Marsico F, Renga F, Dell’Aversana S, Esposito I, Marciano C, et al. The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev. 2020 Jan;25(1):1-7. DOI: 10.1007/s10741-019-09838-6.
13. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2015 Feb;3(2):105-13. DOI: 10.1016/S2213-8587(14)70219-0.
14. Dhingra R, Vasan RS. Diabetes and the risk of heart failure. Heart Fail Clin. 2012;8:125-33. DOI: 10.1016/j.hfc.2011.08.008.
15. van der Wal HH, van Deursen VM, van der Meer P, Voors AA. Comorbidities in Heart Failure. Handb Exp Pharmacol. 2017;243:35-66. DOI: 10.1007/164_2017_27.
16. Khanyukov OO, Pesotskaya LA, Sapozhnychenko LV. Prevalence and Pathogenesis of Anemia in Chronic Heart Failure. Ukrainian Journal of Medicine, Biology and Sport. 2022;7(5):49-56. DOI: 10.26693/jmbs07.05.049.

Publication of the article:

«Bulletin of problems biology and medicine», 2024 Issue 1, 172, 239-246 pages, index UDC 616.12-008.46-036.1-005.4-06-055

DOI:

10.29254/2077-4214-2024-1-172-239-246